Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.

Influenza Other Respir Viruses · 2015 · PMC4474493 · PMID 25847510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

68 A clinical trial in otherwise healthy RSV-infected adults showed a trend towards reduced mean viral titres and clinical severity scores, although neither reached statistical significance. 69 ALN-RSV01 has also been tested in a small cohort of RSV-infected lung transplant recipients ( n = 24; ALN-RSV01 = 16, placebo = 8).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.